Galmed Pharmaceuticals (GLMD) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Galmed Pharmaceuticals Ltd. has entered into a sales agreement with JonesTrading Institutional Services LLC, allowing the company to issue and sell ordinary shares at their discretion. This strategic move signals Galmed’s effort to leverage market opportunities and could potentially impact its stock value as shares are sold in at-the-market offerings.
For further insights into GLMD stock, check out TipRanks’ Stock Analysis page.